Cite

HARVARD Citation

    Wu, J. et al. (2022). Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation. Medicine. 101 (24), pp. e29381-. [Online]. 
  
Back to record